Follow the 진양제약 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 진양제약 has recorded 17 public disclosures. Market capitalisation: €53.4bn. The latest transaction was reported on 18 May 2026 (Sale). Among the most active insiders: 진양제약. Every trade is openly available.
17
Insider Decl.
n/a
Thresholds
n/a
7 ops.
Buy Volume
n/a
2 ops.
Sell Volume
25Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,241 of 29,064 companies
72.7
score / 100
Value
73
Quality
72
FCF yld-3.8%
Earn yld39%
EV/EBITDA4.1x
ROE16%
Gross mgn65%
Net mgn18%
Debt/EBITDA2.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.